# EDGAR Filing Document

**Accession Number:** 0000711377
**File Stem:** 0001193125-25-257565
**Filing Date:** 2025-10
**Character Count:** 17408
**Document Hash:** d1e45c5b4ee85ab0e884df16c8292f56
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-257565.hdr.sgml**: 20251030

**ACCESSION NUMBER**: 0001193125-25-257565

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20251030

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251030

**DATE AS OF CHANGE**: 20251030

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NEOGEN CORP
- **CENTRAL INDEX KEY:** 0000711377
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 382367843
- **STATE OF INCORPORATION:** MI
- **FISCAL YEAR END:** 0531

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-17988
- **FILM NUMBER:** 251432407

**BUSINESS ADDRESS:**
- **STREET 1:** 620 LESHER PLACE
- **CITY:** LANSING
- **STATE:** MI
- **ZIP:** 48912
- **BUSINESS PHONE:** 5173729200

**MAIL ADDRESS:**
- **STREET 1:** 620 LESHER PLACE
- **CITY:** LANSING
- **STATE:** MI
- **ZIP:** 48912

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

## FORM 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** October 30, 2025<br>

------

Neogen Corporation

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Michigan | 0-17988 | 38-2367843 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 620 Lesher Place |  |  |
| Lansing**,** Michigan |  | 48912 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** (517) 372-9200<br>

N/A<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Common Stock, $0.16 par value per share | NEOG | Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

## Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 30, 2025, Neogen Corporation (the "Company") announced the appointment of Bryan Riggsbee as Senior Vice President and Chief Financial Officer, effective November 3, 2025. Mr. Riggsbee will report directly to Mike Nassif, President and Chief Executive Officer.

Mr. Riggsbee, 55, joins Neogen from bioMérieux, where he most recently served as Chief Financial Officer, North America, overseeing a $2 billion business and multiple manufacturing sites across the region. Prior to that, Mr. Riggsbee spent nearly a decade as Chief Financial Officer at Myriad Genetics, where he led the company's finance, accounting, and investor relations functions and played a key role in expanding the company's portfolio and partnerships, as well as supporting growth into new international markets. Earlier in his career, he held senior finance roles at Laboratory Corporation of America (LabCorp), GE, and KPMG.

Mr. Riggsbee currently serves on the Board of Directors of CareDx, Inc., having been appointed in March 2024. He holds bachelor's degrees in Political Science from the University of North Carolina at Chapel Hill and in Accounting from North Carolina State University, as well as an MBA from Northwestern University's Kellogg School of Management. He is also a Certified Public Accountant (CPA).

**Compensatory Arrangements**

In connection with Mr. Riggsbee's appointment, the Compensation & Talent Management Committee of the Board of Directors approved the following compensation arrangements:

**Base Salary**: An annual base salary of $600,000.

**Annual Bonus**: Eligible to participate in the Company's Incentive Compensation Plan ("ICP"), with a target bonus opportunity equal to 80% of annual base salary. The ICP measures both Company financial metrics and personal performance with an opportunity between 0 – 250% of the target. For Fiscal Year 2026, Mr. Riggsbee will be eligible for the full year (no proration).

**Long-Term Incentive Plan**: Eligible for an annual grant of equity with a target of $2,000,000 in value at grant with a composition as approved by the Compensation & Talent Management Committee.

**Sign-On Equity Grant**: Mr. Riggsbee will receive a special, one-time equity inducement grant of $2,250,000, comprised of 50% stock options with a three-year ratable vesting schedule and 50% performance share units ("PSUs") aligned with the Company's FY26 PSU Plan.

**Sign-On Cash Award**: Mr. Riggsbee will receive a one-time cash award of $250,000 to be paid by December 31, 2025, which he will be required to repay the Company if his employment terminates within one year.

**Relocation**: Mr. Riggsbee will relocate to Michigan within twenty-four (24) months of service and will receive reasonably and customary relocation benefits, including reasonable and customary realtor fees and closing costs related to the sale of his current home and the purchase of a new home, expenses related to the movement of household goods, and two (2) house hunting trips. Mr. Riggsbee will be required to repay 100% of these relocation benefits if he terminates his service within one (1) year of relocating to Michigan and 50% if he terminates his service within two (2) years of relocating to Michigan.

**Health & Welfare Benefits**: Mr. Riggsbee is eligible to participate in the Company's health and welfare benefits programs on the same basis as other senior executives, including health and welfare benefits, 401(k) plan participation, and any applicable perquisites; such benefits being effective with his hire date.

The foregoing description of Mr. Riggsbee's compensation is qualified in its entirety by the terms of his offer letter, which is included as an exhibit.

Mr. Riggsbee's employment is at-will, subject to customary pre-employment conditions, including background verification and execution of Neogen's standard Non-Disclosure, Non-Competition, and Non-Solicitation Agreement.

**Item 8.01 Other Events.**

On October 30, 2025, Neogen issued a press release announcing the appointment of a new Chief Financial Officer.

------

## Item 9.01 Financial Statements and Exhibits.
(d) Exhibits

---

| | |
|:---|:---|
| 10.1 | [<u>Offer Letter between Neogen Corporation and Bryan Riggsbee dated October 24, 2025.</u>](neog-ex10_1.htm) |
| 99.1 | [<u>Press Release issued by Neogen Corporation on October 30, 2025, announcing appointment of Bryan Riggsbee as Senior Vice President and Chief Financial Officer.</u>](neog-ex99_1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | NEOGEN CORPORATION |
| Date: | October 30, 2025 | By:  | /s/ Amy M. Rocklin |
|  |  |  | Name: Amy M. Rocklin<br>Title: Chief Legal & Compliance Officer, Corporate Secretary |

---

------

## Exhibit 10.1

October 24, 2025

Bryan Riggsbee

1338 S Foothill Dr PMB 308

Salt Lake City, UT 84108

Dear Bryan,

We are excited you've chosen to join the Neogen Team!

You are being offered employment at Neogen Corporation as Senior Vice President & Chief Financial Officer and will report to Mike Nassif, President & Chief Executive Officer. Your date of hire will be no later than November 17, 2025.

**Base Salary:** You will be classified as a salaried, exempt employee. Your annual base salary will be $600,000.00 per year paid bi-weekly following the Neogen U.S. payroll schedule.

**Annual Bonus:** You will be eligible to participate in the Neogen Incentive Compensation Plan (ICP) with a target of 80% of your base salary. The ICP measures both Company financial metrics and your personal performance with an opportunity between 0 – 250% of your target. You will be eligible for a full year, non-pro-rated award in your first year with Neogen. Please refer to the ICP Fact Sheet for specific details and plan provisions.

**Long-Term Incentive Plan:** Subject to your acceptance of this employment offer and the approval of the Compensation & Talent Management Committee of the Neogen Board of Directors ("Committee"), a recommendation will be made for an annual grant of equity with a target of $2,000,000.00. Annual awards are typically made in August each year. The form and timing of this or any future award are subject to Compensation Committee approval.

**Sign-On Equity Grant:** Subject to your acceptance of this employment offer and the approval of the Committee, a recommendation will be made for a special, one-time target equity grant of $2,250,000.00 which will be comprised of 50% Stock Options and 50% Performance Share Units (PSUs) aligned with the FY26 PSU Plan. This grant will be made on your hire date.

**Sign-On Cash Award:** You will be eligible for a one-time cash award of $250,000.00 to be paid December 31, 2025. This payment is subject to a one-year repayment agreement.

**Health & Welfare Benefits:** You will be eligible to elect health and welfare benefits (medical, dental, vision, etc.). effective with your date of hire. You will have twenty-one (21) days from your hire date to enroll, otherwise your next opportunity will be during our open enrollment period. Please refer to the Neogen Benefits-At-A-Glance for details.

**Relocation:** Neogen will provide you with relocation benefits to establish a residence in Michigan, which will be further detailed in a separate relocation agreement. It is agreed that, within 24 months of service, that you

------

will establish a residence in Michigan within reasonable commuting distance to the Company's offices, and maintain your office at the Company's headquarters. The Company will provide for reasonable and customary realtor fees and closing costs related to the sale of your home and the purchase of a new home, in addition expenses related to the movement of household goods from your current home to your new home. You and your spouse will also be entitled to two house hunting trips. These relocation benefits must be initiated within 24 months of your date of hire.

Relocation benefits will be subject to a two-year repayment agreement. In the event you voluntarily terminate your employment with Neogen before completing two years of service following your relocation, you will be subject to the following repayment schedule:

• 100% of the relocation costs if you terminate your employment within one (1) year of your relocation to Michigan.

• 50% of the relocation costs if you terminate your employment between one (1) and two (2) years following your relocation to Michigan.

Prior to relocation, the Company will reimburse you for reasonable and customary travel expenses to and from Michigan and/or to other Company locations, including airfare and hotel accommodations in accordance with the Neogen travel policy.

**Paid-Time-Off (PTO):** You will be eligible for Neogen's self-managed Paid Time Off (PTO) program for U.S. exempt employees. This program provides flexibility to take time off at your discretion, subject to manager approval and the needs of the business, in alignment with the expectations of your role.

**"At Will" Employment:** This letter does not constitute an employment contract, nor should it be construed as a guarantee of employment for any period of time. All employees of Neogen are hired on an "at will" basis and either the Company or the employee may terminate with or without cause at any time.

**Employment Offer Contingencies:** Please be advised that your employment is contingent upon the results of a criminal background check and substance evaluation. Your employment is also contingent upon proving documentation to complete the I-9 Form for employment eligibility verification required by the U.S. Department of Homeland Security, U.S. Citizenship and Immigration Services.

**Required Non-Disclosure Agreement:** All employees of Neogen are required to sign a Non-Disclosure, Non-Competitive, Non-Solicitation and Property Assignment Agreement upon hire. A copy is enclosed with your offer.

The above information regarding compensation and benefits represents programs being offered to you and/or are currently in place. These programs are subject to change based on many factors including performance, economic conditions and change initiated or implemented by the various insurance provers.

Should you desire any additional clarification or discussion on the terms of this offer, please don't hesitate to contact me. This offer is valid through October 28, 2025.

We look forward to working with you!

------

Sincerely,

Kevin Burke

Chief Human Resources Officer

Offer Acceptance:

________________________________________________

Bryan Riggsbee Date

------

## Exhibit 99.1

**FOR IMMEDIATE RELEASE** 

**Neogen® Corporation Announces** 

**Appointment of Bryan Riggsbee as Chief Financial Officer**

**LANSING, Mich., October 30, 2025** — Neogen® Corporation (NASDAQ: NEOG), a global leader of food safety solutions, is pleased to announce the appointment of Bryan Riggsbee as its new Chief Financial Officer effective November 3, 2025. Riggsbee will oversee Neogen's global finance organization and join the company's Executive Leadership Team, reporting directly to Chief Executive Officer Mike Nassif. To ensure a smooth transition, David Naemura is expected to remain with the Company until the end of the calendar year.

Riggsbee brings over 25 years of financial leadership experience across the diagnostics and healthcare industries. He joins Neogen from bioMérieux where he served as Chief Financial Officer of its $2 billion North American business. Prior to that, Riggsbee spent nearly a decade as Chief Financial Officer at Myriad Genetics, where he led the company's finance, accounting, and investor relations functions and played a key role in expanding the company's portfolio and partnerships, as well as supporting growth into new international markets. Earlier in his career, he held senior finance roles at Laboratory Corporation of America (LabCorp), GE, and KPMG.

"Bryan's track record of driving disciplined growth and operational excellence across complex global organizations makes him a strong addition to our leadership team," said Mike Nassif, Neogen's Chief Executive Officer and President. "His extensive diagnostics background and collaborative approach will be invaluable as we continue executing our strategy to strengthen performance and deliver sustainable growth."

"Neogen's focus on protecting the world's food supply reflects a purpose that deeply resonates with me," Riggsbee said. "I look forward to working with this exceptional team to advance our strategy, strengthen execution, and deliver lasting value for our stakeholders."

Riggsbee holds bachelor's degrees in political science from the University of North Carolina at Chapel Hill and in accounting from North Carolina State University, as well as an MBA from Northwestern University's Kellogg School of Management.

**About Neogen** 

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

**Contact** 

PR@Neogen.com

###

------